Cargando…

Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR

BACKGROUND: CD infections (CDI) may be viewed by healthcare workers (HCW) as an unpreventable consequence of antibiotics (abx). The purpose of CDAT was to use patient cases in real time to educate HCW on CD diagnostic, treatment and prevention practices including appropriate abx and proton-pump inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Markou, Theodore, Fabre, Valeria, Dzintars, Kathryn, Avdic, Edina, Shulder, Stephanie, Andonian, Jennifer, Rock, Clare, Cosgrove, Sara E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630981/
http://dx.doi.org/10.1093/ofid/ofx163.990
_version_ 1783269340318007296
author Markou, Theodore
Fabre, Valeria
Dzintars, Kathryn
Avdic, Edina
Shulder, Stephanie
Andonian, Jennifer
Rock, Clare
Cosgrove, Sara E
author_facet Markou, Theodore
Fabre, Valeria
Dzintars, Kathryn
Avdic, Edina
Shulder, Stephanie
Andonian, Jennifer
Rock, Clare
Cosgrove, Sara E
author_sort Markou, Theodore
collection PubMed
description BACKGROUND: CD infections (CDI) may be viewed by healthcare workers (HCW) as an unpreventable consequence of antibiotics (abx). The purpose of CDAT was to use patient cases in real time to educate HCW on CD diagnostic, treatment and prevention practices including appropriate abx and proton-pump inhibitors (PPI) use. METHODS: From 7/17/16 to 5/6/17, Johns Hopkins abx stewardship team reviewed positive CD PCRs in inpatient to determine whether they had CDI or colonization (no diarrhea or an alternate cause) and if prevention and management was optimal. Included in this time are 2 surveillance periods (SP) (SP1: 7/17–9/27/16 and SP2: 12/18/16–3/30/17). During SP1, there was no contact with HCW. SP2 followed the intervention, and allowed assessment of sustained practice changes. During the intervention periods (IP) (IP1: 10/9–12/17/16 and IP2: 3/31–5/6/17), teaching points for optimizing care for each case were shared and discussed in person with the HCW team, including prescribers and nursing. Compliance with recommendations at 48 hours was assessed. Chi-square test was used to compare sub-optimal management for each variable in different time periods. RESULTS: We assessed 217 cases in the SPs and 96 cases in the IPs. 75 of 96 cases reviewed in the IPs required intervention. CDAT spoke to 74 teams, which led to a change in the care of patients in 49 cases (65%). Compliance with recommendations were as follows: 1) stop or modify CDI therapy, 53%, (39 cases); 2) stop PPI therapy, 52% (15 cases); 3) stop laxatives, 53% (9 cases); 4) stop or modify non-CDI abx, 46% (16 cases); and 5) improve BM documentation, 58% (11 cases). The Figure shows proportions of patients with suboptimal CD management without (SPs) or before (IPs) CDAT intervention in each period. There were no changes in practice between the SP1 and IP1. Between the SP1 and IP2, significant improvement in BM documentation was seen (P = 0.007). No differences were observed for other variables, although there was a trend towards improved CD therapy (P = 0.09). CONCLUSION: Overall, prescribers did not independently change practice as a result of daily contact with CDAT; however, they were responsive to CDAT recommendations. BM documentation, the only nursing intervention, improved significantly. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5630981
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56309812017-11-07 Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR Markou, Theodore Fabre, Valeria Dzintars, Kathryn Avdic, Edina Shulder, Stephanie Andonian, Jennifer Rock, Clare Cosgrove, Sara E Open Forum Infect Dis Abstracts BACKGROUND: CD infections (CDI) may be viewed by healthcare workers (HCW) as an unpreventable consequence of antibiotics (abx). The purpose of CDAT was to use patient cases in real time to educate HCW on CD diagnostic, treatment and prevention practices including appropriate abx and proton-pump inhibitors (PPI) use. METHODS: From 7/17/16 to 5/6/17, Johns Hopkins abx stewardship team reviewed positive CD PCRs in inpatient to determine whether they had CDI or colonization (no diarrhea or an alternate cause) and if prevention and management was optimal. Included in this time are 2 surveillance periods (SP) (SP1: 7/17–9/27/16 and SP2: 12/18/16–3/30/17). During SP1, there was no contact with HCW. SP2 followed the intervention, and allowed assessment of sustained practice changes. During the intervention periods (IP) (IP1: 10/9–12/17/16 and IP2: 3/31–5/6/17), teaching points for optimizing care for each case were shared and discussed in person with the HCW team, including prescribers and nursing. Compliance with recommendations at 48 hours was assessed. Chi-square test was used to compare sub-optimal management for each variable in different time periods. RESULTS: We assessed 217 cases in the SPs and 96 cases in the IPs. 75 of 96 cases reviewed in the IPs required intervention. CDAT spoke to 74 teams, which led to a change in the care of patients in 49 cases (65%). Compliance with recommendations were as follows: 1) stop or modify CDI therapy, 53%, (39 cases); 2) stop PPI therapy, 52% (15 cases); 3) stop laxatives, 53% (9 cases); 4) stop or modify non-CDI abx, 46% (16 cases); and 5) improve BM documentation, 58% (11 cases). The Figure shows proportions of patients with suboptimal CD management without (SPs) or before (IPs) CDAT intervention in each period. There were no changes in practice between the SP1 and IP1. Between the SP1 and IP2, significant improvement in BM documentation was seen (P = 0.007). No differences were observed for other variables, although there was a trend towards improved CD therapy (P = 0.09). CONCLUSION: Overall, prescribers did not independently change practice as a result of daily contact with CDAT; however, they were responsive to CDAT recommendations. BM documentation, the only nursing intervention, improved significantly. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5630981/ http://dx.doi.org/10.1093/ofid/ofx163.990 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Markou, Theodore
Fabre, Valeria
Dzintars, Kathryn
Avdic, Edina
Shulder, Stephanie
Andonian, Jennifer
Rock, Clare
Cosgrove, Sara E
Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR
title Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR
title_full Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR
title_fullStr Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR
title_full_unstemmed Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR
title_short Clostridium difficile (CD) Action Team (CDAT): An Intervention to Improve Care for Patients with a Positive CD PCR
title_sort clostridium difficile (cd) action team (cdat): an intervention to improve care for patients with a positive cd pcr
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630981/
http://dx.doi.org/10.1093/ofid/ofx163.990
work_keys_str_mv AT markoutheodore clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT fabrevaleria clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT dzintarskathryn clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT avdicedina clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT shulderstephanie clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT andonianjennifer clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT rockclare clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr
AT cosgrovesarae clostridiumdifficilecdactionteamcdataninterventiontoimprovecareforpatientswithapositivecdpcr